Differential Effect of B-Vitamin Therapy by Antiplatelet Use on Risk of Recurrent Vascular Events After Stroke [Brief Reports]

Conclusions— High-dose B vitamin therapy may be associated with a higher risk of recurrent stroke among stroke survivors taking antiplatelets, but does not have a significant effect on recurrent stroke risk in those who are not on antiplatelets. Future randomized controlled trials may consider evaluating the effect of homocysteine lowering among stroke survivors with elevated homocysteine who are not on antiplatelet therapy.
Source: Stroke - Category: Neurology Authors: Tags: Secondary prevention, Antiplatelets, Endothelium/vascular type/nitric oxide Brief Reports Source Type: research